{"license":"https://creativecommons.org/licenses/by/4.0/","dataset":"event-entities","count":10,"summary":{"policyEntityCount":21,"relationshipCount":31,"officialEventCount":14,"linkedEventCount":12,"unlinkedEventCount":2,"marketCount":7,"sourceCount":11,"agencyCount":4,"profileCrosswalkCount":6,"firstYear":2019,"latestYear":2026,"spanLabel":"2019-2026"},"guardrail":"A relationship means an official source names the organization in connection with the dated record. It does not by itself establish liability, market power, ownership, control, or that the organization participates in every market linked to that record.","crosswalkGuardrail":"Optional participant and operator crosswalks are observatory navigation aids based on matched public labels. They are not legal-entity, affiliate, beneficial-owner, or corporate-control determinations.","eventFilters":{"event":null,"eventMatched":null,"events":["evt-pbm-insulin-complaint-2024","evt-pbm-express-scripts-settlement-2026","evt-pbm-caremark-settlement-2026"],"eventsMatched":true,"matchedEventCount":3,"matchedEventIds":["evt-pbm-insulin-complaint-2024","evt-pbm-express-scripts-settlement-2026","evt-pbm-caremark-settlement-2026"],"unmatchedEvents":[],"stage":null,"stageMatched":null,"type":null,"typeMatched":null,"agency":null,"proceeding":"pbm-insulin-rebate-case","proceedingMatched":true,"proceedingId":"proceeding-pbm-insulin","proceedingSlug":"pbm-insulin-rebate-case"},"rows":[{"id":"peel-ascent-complaint","eventId":"evt-pbm-insulin-complaint-2024","eventDate":"2024-09-20","eventTitle":"FTC files administrative complaint against the three largest PBMs","eventStage":"litigation","eventType":"complaint","agency":"Federal Trade Commission","docketNumber":"Docket No. 9437","entityId":"pent-ascent-health","entitySlug":"ascent-health-services-llc","entityName":"Ascent Health Services, LLC","role":"respondent","roleLabel":"Respondent","evidenceSummary":"The FTC administrative complaint names affiliated GPO Ascent Health Services as a respondent.","markets":[{"id":"mkt-pbm","slug":"us-pharmacy-benefit-management","name":"U.S. pharmacy benefit management"}],"sourceId":"ftc-pbm-insulin-complaint-2024","sourceTitle":"FTC Sues Prescription Drug Middlemen for Artificially Inflating Insulin Drug Prices","sourcePublisher":"Federal Trade Commission","sourceUrl":"https://www.ftc.gov/news-events/news/press-releases/2024/09/ftc-sues-prescription-drug-middlemen-artificially-inflating-insulin-drug-prices","sourceAccessDate":"2026-07-17","profileHref":null,"profileKind":null,"policyEntityProfileHref":"/enforcement/entities/ascent-health-services-llc","recordProfileHref":"/enforcement/records/pbm-insulin-complaint-2024","enforcementHref":"/enforcement?policyEntity=ascent-health-services-llc&enforcementEvent=evt-pbm-insulin-complaint-2024#enforcement-relationship-atlas","guardrail":"A relationship means an official source names the organization in connection with the dated record. It does not by itself establish liability, market power, ownership, control, or that the organization participates in every market linked to that record.","crosswalkGuardrail":"Optional participant and operator crosswalks are observatory navigation aids based on matched public labels. They are not legal-entity, affiliate, beneficial-owner, or corporate-control determinations.","sourceProfileHref":"/sources/ftc-pbm-insulin-complaint-2024"},{"id":"peel-caremark-complaint","eventId":"evt-pbm-insulin-complaint-2024","eventDate":"2024-09-20","eventTitle":"FTC files administrative complaint against the three largest PBMs","eventStage":"litigation","eventType":"complaint","agency":"Federal Trade Commission","docketNumber":"Docket No. 9437","entityId":"pent-caremark-rx","entitySlug":"caremark-rx-llc","entityName":"Caremark Rx, LLC","role":"respondent","roleLabel":"Respondent","evidenceSummary":"The FTC administrative complaint names Caremark Rx as a respondent.","markets":[{"id":"mkt-pbm","slug":"us-pharmacy-benefit-management","name":"U.S. pharmacy benefit management"}],"sourceId":"ftc-pbm-insulin-complaint-2024","sourceTitle":"FTC Sues Prescription Drug Middlemen for Artificially Inflating Insulin Drug Prices","sourcePublisher":"Federal Trade Commission","sourceUrl":"https://www.ftc.gov/news-events/news/press-releases/2024/09/ftc-sues-prescription-drug-middlemen-artificially-inflating-insulin-drug-prices","sourceAccessDate":"2026-07-17","profileHref":null,"profileKind":null,"policyEntityProfileHref":"/enforcement/entities/caremark-rx-llc","recordProfileHref":"/enforcement/records/pbm-insulin-complaint-2024","enforcementHref":"/enforcement?policyEntity=caremark-rx-llc&enforcementEvent=evt-pbm-insulin-complaint-2024#enforcement-relationship-atlas","guardrail":"A relationship means an official source names the organization in connection with the dated record. It does not by itself establish liability, market power, ownership, control, or that the organization participates in every market linked to that record.","crosswalkGuardrail":"Optional participant and operator crosswalks are observatory navigation aids based on matched public labels. They are not legal-entity, affiliate, beneficial-owner, or corporate-control determinations.","sourceProfileHref":"/sources/ftc-pbm-insulin-complaint-2024"},{"id":"peel-emisar-complaint","eventId":"evt-pbm-insulin-complaint-2024","eventDate":"2024-09-20","eventTitle":"FTC files administrative complaint against the three largest PBMs","eventStage":"litigation","eventType":"complaint","agency":"Federal Trade Commission","docketNumber":"Docket No. 9437","entityId":"pent-emisar-pharma","entitySlug":"emisar-pharma-services-llc","entityName":"Emisar Pharma Services LLC","role":"respondent","roleLabel":"Respondent","evidenceSummary":"The FTC administrative complaint names affiliated GPO Emisar Pharma Services as a respondent.","markets":[{"id":"mkt-pbm","slug":"us-pharmacy-benefit-management","name":"U.S. pharmacy benefit management"}],"sourceId":"ftc-pbm-insulin-complaint-2024","sourceTitle":"FTC Sues Prescription Drug Middlemen for Artificially Inflating Insulin Drug Prices","sourcePublisher":"Federal Trade Commission","sourceUrl":"https://www.ftc.gov/news-events/news/press-releases/2024/09/ftc-sues-prescription-drug-middlemen-artificially-inflating-insulin-drug-prices","sourceAccessDate":"2026-07-17","profileHref":null,"profileKind":null,"policyEntityProfileHref":"/enforcement/entities/emisar-pharma-services-llc","recordProfileHref":"/enforcement/records/pbm-insulin-complaint-2024","enforcementHref":"/enforcement?policyEntity=emisar-pharma-services-llc&enforcementEvent=evt-pbm-insulin-complaint-2024#enforcement-relationship-atlas","guardrail":"A relationship means an official source names the organization in connection with the dated record. It does not by itself establish liability, market power, ownership, control, or that the organization participates in every market linked to that record.","crosswalkGuardrail":"Optional participant and operator crosswalks are observatory navigation aids based on matched public labels. They are not legal-entity, affiliate, beneficial-owner, or corporate-control determinations.","sourceProfileHref":"/sources/ftc-pbm-insulin-complaint-2024"},{"id":"peel-express-scripts-complaint","eventId":"evt-pbm-insulin-complaint-2024","eventDate":"2024-09-20","eventTitle":"FTC files administrative complaint against the three largest PBMs","eventStage":"litigation","eventType":"complaint","agency":"Federal Trade Commission","docketNumber":"Docket No. 9437","entityId":"pent-express-scripts","entitySlug":"express-scripts-inc","entityName":"Express Scripts, Inc.","role":"respondent","roleLabel":"Respondent","evidenceSummary":"The FTC administrative complaint names Express Scripts as a respondent.","markets":[{"id":"mkt-pbm","slug":"us-pharmacy-benefit-management","name":"U.S. pharmacy benefit management"}],"sourceId":"ftc-pbm-insulin-complaint-2024","sourceTitle":"FTC Sues Prescription Drug Middlemen for Artificially Inflating Insulin Drug Prices","sourcePublisher":"Federal Trade Commission","sourceUrl":"https://www.ftc.gov/news-events/news/press-releases/2024/09/ftc-sues-prescription-drug-middlemen-artificially-inflating-insulin-drug-prices","sourceAccessDate":"2026-07-17","profileHref":null,"profileKind":null,"policyEntityProfileHref":"/enforcement/entities/express-scripts-inc","recordProfileHref":"/enforcement/records/pbm-insulin-complaint-2024","enforcementHref":"/enforcement?policyEntity=express-scripts-inc&enforcementEvent=evt-pbm-insulin-complaint-2024#enforcement-relationship-atlas","guardrail":"A relationship means an official source names the organization in connection with the dated record. It does not by itself establish liability, market power, ownership, control, or that the organization participates in every market linked to that record.","crosswalkGuardrail":"Optional participant and operator crosswalks are observatory navigation aids based on matched public labels. They are not legal-entity, affiliate, beneficial-owner, or corporate-control determinations.","sourceProfileHref":"/sources/ftc-pbm-insulin-complaint-2024"},{"id":"peel-optumrx-complaint","eventId":"evt-pbm-insulin-complaint-2024","eventDate":"2024-09-20","eventTitle":"FTC files administrative complaint against the three largest PBMs","eventStage":"litigation","eventType":"complaint","agency":"Federal Trade Commission","docketNumber":"Docket No. 9437","entityId":"pent-optumrx","entitySlug":"optumrx-inc","entityName":"OptumRx, Inc.","role":"respondent","roleLabel":"Respondent","evidenceSummary":"The FTC administrative complaint names OptumRx as a respondent.","markets":[{"id":"mkt-pbm","slug":"us-pharmacy-benefit-management","name":"U.S. pharmacy benefit management"}],"sourceId":"ftc-pbm-insulin-complaint-2024","sourceTitle":"FTC Sues Prescription Drug Middlemen for Artificially Inflating Insulin Drug Prices","sourcePublisher":"Federal Trade Commission","sourceUrl":"https://www.ftc.gov/news-events/news/press-releases/2024/09/ftc-sues-prescription-drug-middlemen-artificially-inflating-insulin-drug-prices","sourceAccessDate":"2026-07-17","profileHref":null,"profileKind":null,"policyEntityProfileHref":"/enforcement/entities/optumrx-inc","recordProfileHref":"/enforcement/records/pbm-insulin-complaint-2024","enforcementHref":"/enforcement?policyEntity=optumrx-inc&enforcementEvent=evt-pbm-insulin-complaint-2024#enforcement-relationship-atlas","guardrail":"A relationship means an official source names the organization in connection with the dated record. It does not by itself establish liability, market power, ownership, control, or that the organization participates in every market linked to that record.","crosswalkGuardrail":"Optional participant and operator crosswalks are observatory navigation aids based on matched public labels. They are not legal-entity, affiliate, beneficial-owner, or corporate-control determinations.","sourceProfileHref":"/sources/ftc-pbm-insulin-complaint-2024"},{"id":"peel-zinc-complaint","eventId":"evt-pbm-insulin-complaint-2024","eventDate":"2024-09-20","eventTitle":"FTC files administrative complaint against the three largest PBMs","eventStage":"litigation","eventType":"complaint","agency":"Federal Trade Commission","docketNumber":"Docket No. 9437","entityId":"pent-zinc-health","entitySlug":"zinc-health-services-llc","entityName":"Zinc Health Services, LLC","role":"respondent","roleLabel":"Respondent","evidenceSummary":"The FTC administrative complaint names affiliated GPO Zinc Health Services as a respondent.","markets":[{"id":"mkt-pbm","slug":"us-pharmacy-benefit-management","name":"U.S. pharmacy benefit management"}],"sourceId":"ftc-pbm-insulin-complaint-2024","sourceTitle":"FTC Sues Prescription Drug Middlemen for Artificially Inflating Insulin Drug Prices","sourcePublisher":"Federal Trade Commission","sourceUrl":"https://www.ftc.gov/news-events/news/press-releases/2024/09/ftc-sues-prescription-drug-middlemen-artificially-inflating-insulin-drug-prices","sourceAccessDate":"2026-07-17","profileHref":null,"profileKind":null,"policyEntityProfileHref":"/enforcement/entities/zinc-health-services-llc","recordProfileHref":"/enforcement/records/pbm-insulin-complaint-2024","enforcementHref":"/enforcement?policyEntity=zinc-health-services-llc&enforcementEvent=evt-pbm-insulin-complaint-2024#enforcement-relationship-atlas","guardrail":"A relationship means an official source names the organization in connection with the dated record. It does not by itself establish liability, market power, ownership, control, or that the organization participates in every market linked to that record.","crosswalkGuardrail":"Optional participant and operator crosswalks are observatory navigation aids based on matched public labels. They are not legal-entity, affiliate, beneficial-owner, or corporate-control determinations.","sourceProfileHref":"/sources/ftc-pbm-insulin-complaint-2024"},{"id":"peel-ascent-settlement","eventId":"evt-pbm-express-scripts-settlement-2026","eventDate":"2026-02-04","eventTitle":"FTC announces proposed consent agreement with Express Scripts","eventStage":"remedy","eventType":"settlement","agency":"Federal Trade Commission","docketNumber":"Docket No. 9437","entityId":"pent-ascent-health","entitySlug":"ascent-health-services-llc","entityName":"Ascent Health Services, LLC","role":"remedy_subject","roleLabel":"Remedy subject","evidenceSummary":"The FTC settlement announcement identifies affiliated group purchasing organization Ascent Health Services among the entities subject to the proposed consent agreement.","markets":[{"id":"mkt-pbm","slug":"us-pharmacy-benefit-management","name":"U.S. pharmacy benefit management"}],"sourceId":"ftc-express-scripts-settlement-2026","sourceTitle":"FTC Secures Landmark Settlement with Express Scripts to Lower Drug Costs for American Patients","sourcePublisher":"Federal Trade Commission","sourceUrl":"https://www.ftc.gov/news-events/news/press-releases/2026/02/ftc-secures-landmark-settlement-express-scripts-lower-drug-costs-american-patients","sourceAccessDate":"2026-07-20","profileHref":null,"profileKind":null,"policyEntityProfileHref":"/enforcement/entities/ascent-health-services-llc","recordProfileHref":"/enforcement/records/pbm-express-scripts-settlement-2026","enforcementHref":"/enforcement?policyEntity=ascent-health-services-llc&enforcementEvent=evt-pbm-express-scripts-settlement-2026#enforcement-relationship-atlas","guardrail":"A relationship means an official source names the organization in connection with the dated record. It does not by itself establish liability, market power, ownership, control, or that the organization participates in every market linked to that record.","crosswalkGuardrail":"Optional participant and operator crosswalks are observatory navigation aids based on matched public labels. They are not legal-entity, affiliate, beneficial-owner, or corporate-control determinations.","sourceProfileHref":"/sources/ftc-express-scripts-settlement-2026"},{"id":"peel-express-scripts-settlement","eventId":"evt-pbm-express-scripts-settlement-2026","eventDate":"2026-02-04","eventTitle":"FTC announces proposed consent agreement with Express Scripts","eventStage":"remedy","eventType":"settlement","agency":"Federal Trade Commission","docketNumber":"Docket No. 9437","entityId":"pent-express-scripts","entitySlug":"express-scripts-inc","entityName":"Express Scripts, Inc.","role":"remedy_subject","roleLabel":"Remedy subject","evidenceSummary":"The FTC settlement announcement identifies Express Scripts among the entities subject to the proposed consent agreement.","markets":[{"id":"mkt-pbm","slug":"us-pharmacy-benefit-management","name":"U.S. pharmacy benefit management"}],"sourceId":"ftc-express-scripts-settlement-2026","sourceTitle":"FTC Secures Landmark Settlement with Express Scripts to Lower Drug Costs for American Patients","sourcePublisher":"Federal Trade Commission","sourceUrl":"https://www.ftc.gov/news-events/news/press-releases/2026/02/ftc-secures-landmark-settlement-express-scripts-lower-drug-costs-american-patients","sourceAccessDate":"2026-07-20","profileHref":null,"profileKind":null,"policyEntityProfileHref":"/enforcement/entities/express-scripts-inc","recordProfileHref":"/enforcement/records/pbm-express-scripts-settlement-2026","enforcementHref":"/enforcement?policyEntity=express-scripts-inc&enforcementEvent=evt-pbm-express-scripts-settlement-2026#enforcement-relationship-atlas","guardrail":"A relationship means an official source names the organization in connection with the dated record. It does not by itself establish liability, market power, ownership, control, or that the organization participates in every market linked to that record.","crosswalkGuardrail":"Optional participant and operator crosswalks are observatory navigation aids based on matched public labels. They are not legal-entity, affiliate, beneficial-owner, or corporate-control determinations.","sourceProfileHref":"/sources/ftc-express-scripts-settlement-2026"},{"id":"peel-caremark-settlement","eventId":"evt-pbm-caremark-settlement-2026","eventDate":"2026-07-14","eventTitle":"FTC announces proposed consent agreement with Caremark","eventStage":"remedy","eventType":"settlement","agency":"Federal Trade Commission","docketNumber":"Docket No. 9437","entityId":"pent-caremark-rx","entitySlug":"caremark-rx-llc","entityName":"Caremark Rx, LLC","role":"remedy_subject","roleLabel":"Remedy subject","evidenceSummary":"The FTC settlement announcement identifies Caremark among the entities subject to the proposed consent agreement.","markets":[{"id":"mkt-pbm","slug":"us-pharmacy-benefit-management","name":"U.S. pharmacy benefit management"}],"sourceId":"ftc-caremark-settlement-2026","sourceTitle":"FTC Secures Major Settlement with Caremark Resolving Antitrust Case Against Second Drug Middleman","sourcePublisher":"Federal Trade Commission","sourceUrl":"https://www.ftc.gov/news-events/news/press-releases/2026/07/ftc-secures-major-settlement-caremark-resolving-antitrust-case-against-second-drug-middleman","sourceAccessDate":"2026-07-20","profileHref":null,"profileKind":null,"policyEntityProfileHref":"/enforcement/entities/caremark-rx-llc","recordProfileHref":"/enforcement/records/pbm-caremark-settlement-2026","enforcementHref":"/enforcement?policyEntity=caremark-rx-llc&enforcementEvent=evt-pbm-caremark-settlement-2026#enforcement-relationship-atlas","guardrail":"A relationship means an official source names the organization in connection with the dated record. It does not by itself establish liability, market power, ownership, control, or that the organization participates in every market linked to that record.","crosswalkGuardrail":"Optional participant and operator crosswalks are observatory navigation aids based on matched public labels. They are not legal-entity, affiliate, beneficial-owner, or corporate-control determinations.","sourceProfileHref":"/sources/ftc-caremark-settlement-2026"},{"id":"peel-zinc-settlement","eventId":"evt-pbm-caremark-settlement-2026","eventDate":"2026-07-14","eventTitle":"FTC announces proposed consent agreement with Caremark","eventStage":"remedy","eventType":"settlement","agency":"Federal Trade Commission","docketNumber":"Docket No. 9437","entityId":"pent-zinc-health","entitySlug":"zinc-health-services-llc","entityName":"Zinc Health Services, LLC","role":"remedy_subject","roleLabel":"Remedy subject","evidenceSummary":"The FTC settlement announcement identifies affiliated group purchasing organization Zinc Health Services among the entities subject to the proposed consent agreement.","markets":[{"id":"mkt-pbm","slug":"us-pharmacy-benefit-management","name":"U.S. pharmacy benefit management"}],"sourceId":"ftc-caremark-settlement-2026","sourceTitle":"FTC Secures Major Settlement with Caremark Resolving Antitrust Case Against Second Drug Middleman","sourcePublisher":"Federal Trade Commission","sourceUrl":"https://www.ftc.gov/news-events/news/press-releases/2026/07/ftc-secures-major-settlement-caremark-resolving-antitrust-case-against-second-drug-middleman","sourceAccessDate":"2026-07-20","profileHref":null,"profileKind":null,"policyEntityProfileHref":"/enforcement/entities/zinc-health-services-llc","recordProfileHref":"/enforcement/records/pbm-caremark-settlement-2026","enforcementHref":"/enforcement?policyEntity=zinc-health-services-llc&enforcementEvent=evt-pbm-caremark-settlement-2026#enforcement-relationship-atlas","guardrail":"A relationship means an official source names the organization in connection with the dated record. It does not by itself establish liability, market power, ownership, control, or that the organization participates in every market linked to that record.","crosswalkGuardrail":"Optional participant and operator crosswalks are observatory navigation aids based on matched public labels. They are not legal-entity, affiliate, beneficial-owner, or corporate-control determinations.","sourceProfileHref":"/sources/ftc-caremark-settlement-2026"}]}